Levobupivacaine and its use
US6514994B2 · kind B2 · utility
2Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2001 |
| Grant date | Feb 4, 2003 |
| Priority date | — |
| Expiry date | Oct 1, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P23/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A unit dosage and pharmaceutical delivery system for anaesthetizing a human patient prior to major surgery, which comprise between 200 mg and 300 mg of levobupivacaine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.